SG/CALL/SARTORIUS STEDIM BIO/220/0.025/20.12.24 Stock

Warrant

294AS

DE000SU0S1L9

Market Closed - Euronext Paris 12:30:00 2024-06-21 EDT
0.195 EUR -4.88% Intraday chart for SG/CALL/SARTORIUS STEDIM BIO/220/0.025/20.12.24
Current month-53.57%
1 month-66.95%
Date Price Change
24-06-21 0.195 -4.88%
24-06-20 0.205 +10.81%
24-06-19 0.185 -48.61%
24-06-18 0.36 +9.09%
24-06-17 0.33 -13.16%

Real-time Euronext Paris

Last update June 21, 2024 at 12:30 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer Société Générale Société Générale
294AS
ISINDE000SU0S1L9
Date issued 2023-10-16
Strike 220
Maturity 2024-12-20 (182 Days)
Parity 40 : 1
Emission price 0.86
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.18
Lowest since issue 0.175
Delta0.26x
Omega 5.227
Premium44.73x
Gearing20.18x
Moneyness 0.7155
Difference Strike 62.6
Difference Strike %+28.45%
Spread 0.01
Spread %5.00%
Theoretical value 0.1950
Implied Volatility 53.68 %
Total Loss Probability 84.74 %
Intrinsic value 0.000000
Present value 0.1950
Break even 227.80 €
Theta-0.01x
Vega0.01x
Rho0x

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
157.4 EUR
Average target price
248.8 EUR
Spread / Average Target
+58.09%
Consensus
  1. Stock Market
  2. Warrants
  3. 294AS Warrant